Two crystal structures of human neutrophil collagenase, one complexed with a primed- and the other with an unprimed-side inhibitor: Implications for drug design

Gavuzzo E, Pochetti G, Mazza F, Gallina C, Gorini B, D'Alessio S, Pieper M, Tschesche H, Tucker PA (2000)
JOURNAL OF MEDICINAL CHEMISTRY 43(18): 3377-3385.

Zeitschriftenaufsatz | Veröffentlicht | Englisch
 
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Gavuzzo, E; Pochetti, G; Mazza, F; Gallina, C; Gorini, B; D'Alessio, S; Pieper, M; Tschesche, HaraldUniBi; Tucker, PA
Abstract / Bemerkung
Two crystal structures of human neutrophil collagenase (HNC, MMP-8), one complexed with a primed- and the other with an unprimed-side inhibitor, were determined using synchrotron radiation at 100 K. Both inhibitors contain non-hydroxamate zinc-binding functions. The Pro-Leu-L-Trp(P)(OH)(2) occupies the unprimed region of the active site, furnishes new structural information regarding interaction between the catalytic zinc ion and the phosphonate group, and is the only example of occupation of the S-1 subsite of MMP-8 by the bulky tryptophan side chain. The (R)-2-(biphenyl-4-ylsulfonyl)-1,2,3,4-tetrahydroisochinolin-3-carboxylic acid, a conformationally constrained D-Tic derivative, accommodates its biphenyl substituent into the deep primary specificity S-1' subsite, inducing a widening of the entrance to this pocket; this modification of the protein, mainly consisting in a shift of the segment centered at Pro217, is observed for the first time in MMP-8 complexes. Cation-aromatic interactions can stabilize the formation of both complexes, and the beneficial effect of aromatic substituents in proximity of the catalytic zinc ion is discussed. The phosphonate group bound to either a primed- or unprimed-side inhibitor maintains the same relative position with respect to the catalytic zinc ion, suggesting that this binding function can be exploited for the design of combined inhibitors assembled to interact with both primed and unprimed regions of the active cleft.
Erscheinungsjahr
2000
Zeitschriftentitel
JOURNAL OF MEDICINAL CHEMISTRY
Band
43
Ausgabe
18
Seite(n)
3377-3385
ISSN
0022-2623
eISSN
1520-4804
Page URI
https://pub.uni-bielefeld.de/record/1619051

Zitieren

Gavuzzo E, Pochetti G, Mazza F, et al. Two crystal structures of human neutrophil collagenase, one complexed with a primed- and the other with an unprimed-side inhibitor: Implications for drug design. JOURNAL OF MEDICINAL CHEMISTRY. 2000;43(18):3377-3385.
Gavuzzo, E., Pochetti, G., Mazza, F., Gallina, C., Gorini, B., D'Alessio, S., Pieper, M., et al. (2000). Two crystal structures of human neutrophil collagenase, one complexed with a primed- and the other with an unprimed-side inhibitor: Implications for drug design. JOURNAL OF MEDICINAL CHEMISTRY, 43(18), 3377-3385. https://doi.org/10.1021/jm9909589
Gavuzzo, E, Pochetti, G, Mazza, F, Gallina, C, Gorini, B, D'Alessio, S, Pieper, M, Tschesche, Harald, and Tucker, PA. 2000. “Two crystal structures of human neutrophil collagenase, one complexed with a primed- and the other with an unprimed-side inhibitor: Implications for drug design”. JOURNAL OF MEDICINAL CHEMISTRY 43 (18): 3377-3385.
Gavuzzo, E., Pochetti, G., Mazza, F., Gallina, C., Gorini, B., D'Alessio, S., Pieper, M., Tschesche, H., and Tucker, P. A. (2000). Two crystal structures of human neutrophil collagenase, one complexed with a primed- and the other with an unprimed-side inhibitor: Implications for drug design. JOURNAL OF MEDICINAL CHEMISTRY 43, 3377-3385.
Gavuzzo, E., et al., 2000. Two crystal structures of human neutrophil collagenase, one complexed with a primed- and the other with an unprimed-side inhibitor: Implications for drug design. JOURNAL OF MEDICINAL CHEMISTRY, 43(18), p 3377-3385.
E. Gavuzzo, et al., “Two crystal structures of human neutrophil collagenase, one complexed with a primed- and the other with an unprimed-side inhibitor: Implications for drug design”, JOURNAL OF MEDICINAL CHEMISTRY, vol. 43, 2000, pp. 3377-3385.
Gavuzzo, E., Pochetti, G., Mazza, F., Gallina, C., Gorini, B., D'Alessio, S., Pieper, M., Tschesche, H., Tucker, P.A.: Two crystal structures of human neutrophil collagenase, one complexed with a primed- and the other with an unprimed-side inhibitor: Implications for drug design. JOURNAL OF MEDICINAL CHEMISTRY. 43, 3377-3385 (2000).
Gavuzzo, E, Pochetti, G, Mazza, F, Gallina, C, Gorini, B, D'Alessio, S, Pieper, M, Tschesche, Harald, and Tucker, PA. “Two crystal structures of human neutrophil collagenase, one complexed with a primed- and the other with an unprimed-side inhibitor: Implications for drug design”. JOURNAL OF MEDICINAL CHEMISTRY 43.18 (2000): 3377-3385.

17 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

Inhibitory Antibodies Designed for Matrix Metalloproteinase Modulation.
Fischer T, Riedl R., Molecules 24(12), 2019
PMID: 31216704
Triple-helical transition state analogues: a new class of selective matrix metalloproteinase inhibitors.
Lauer-Fields J, Brew K, Whitehead JK, Li S, Hammer RP, Fields GB., J Am Chem Soc 129(34), 2007
PMID: 17672455
N-Hydroxyurea as zinc binding group in matrix metalloproteinase inhibition: mode of binding in a complex with MMP-8.
Campestre C, Agamennone M, Tortorella P, Preziuso S, Biasone A, Gavuzzo E, Pochetti G, Mazza F, Hiller O, Tschesche H, Consalvi V, Gallina C., Bioorg Med Chem Lett 16(1), 2006
PMID: 16242329
Insight into autoproteolytic activation from the structure of cephalosporin acylase: a protein with two proteolytic chemistries.
Kim JK, Yang IS, Shin HJ, Cho KJ, Ryu EK, Kim SH, Park SS, Kim KH., Proc Natl Acad Sci U S A 103(6), 2006
PMID: 16446446
Molecular dynamics simulation of Leishmania major surface metalloprotease GP63 (leishmanolysin).
Bianchini G, Bocedi A, Ascenzi P, Gavuzzo E, Mazza F, Aschi M., Proteins 64(2), 2006
PMID: 16708363
Synthesis and evaluation of new tripeptide phosphonate inhibitors of MMP-8 and MMP-2.
Agamennone M, Campestre C, Preziuso S, Consalvi V, Crucianelli M, Mazza F, Politi V, Ragno R, Tortorella P, Gallina C., Eur J Med Chem 40(3), 2005
PMID: 15725496
Structural basis for the highly selective inhibition of MMP-13.
Engel CK, Pirard B, Schimanski S, Kirsch R, Habermann J, Klingler O, Schlotte V, Weithmann KU, Wendt KU., Chem Biol 12(2), 2005
PMID: 15734645
Future challenges facing the development of specific active-site-directed synthetic inhibitors of MMPs.
Cuniasse P, Devel L, Makaritis A, Beau F, Georgiadis D, Matziari M, Yiotakis A, Dive V., Biochimie 87(3-4), 2005
PMID: 15781327
Design, modelling, synthesis and biological evaluation of peptidomimetic phosphinates as inhibitors of matrix metalloproteinases MMP-2 and MMP-8.
Bianchini G, Aschi M, Cavicchio G, Crucianelli M, Preziuso S, Gallina C, Nastari A, Gavuzzo E, Mazza F., Bioorg Med Chem 13(15), 2005
PMID: 15935680
Crystal structure of the catalytic domain of human matrix metalloproteinase 10.
Bertini I, Calderone V, Fragai M, Luchinat C, Mangani S, Terni B., J Mol Biol 336(3), 2004
PMID: 15095982
Structural aspects of the metzincin clan of metalloendopeptidases.
Gomis-Rüth FX., Mol Biotechnol 24(2), 2003
PMID: 12746556
Computational study of the catalytic domain of human neutrophil collagenase. specific role of the S3 and S'3 subsites in the interaction with a phosphonate inhibitor.
Aschi M, Roccatano D, Di Nola A, Gallina C, Gavuzzo E, Pochetti G, Pieper M, Tschesche H, Mazza F., J Comput Aided Mol Des 16(3), 2002
PMID: 12363219
Tetrahydroisoquinoline-3-carboxylate based matrix-metalloproteinase inhibitors: design, synthesis and structure-activity relationship.
Matter H, Schudok M, Schwab W, Thorwart W, Barbier D, Billen G, Haase B, Neises B, Weithmann K, Wollmann T., Bioorg Med Chem 10(11), 2002
PMID: 12213468
Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®
Quellen

PMID: 10978185
PubMed | Europe PMC

Suchen in

Google Scholar